BCR-ABL1 expression in multiple myeloma cells: A case of mistaken identity?

被引：4
|
作者：
MacLeod, Roderick A. F. [1 ]
Nagel, Stefan [1 ]
Dirks, Wilhelm [1 ]
Drexler, Hans G. [1 ]
机构：
[1] Leibniz Inst DSMZ, Dept Human & Anim Cell Cultures, D-38124 Braunschweig, Germany
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2013年 / 110卷 / 04期
关键词：
LEUKEMIA; LINES;
D O I：
10.1073/pnas.1219862110
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：E270 / E271
页数：2
相关论文
共 50 条
  • [41] Evolution of Human BCR-ABL1 lymphoblastic Leukaemia-Initiating Cells.
    Notta, Faiyaz
    Mullighan, Charles
    Wang, Jean
    Poeppl, Armando G.
    Doulatov, Sergei
    Phillips, Letha A.
    Ma, Jing
    Minden, Mark D.
    Downing, James R.
    Dick, John E.
    BLOOD, 2010, 116 (21) : 451 - 451
  • [42] The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
    Naranie Shanmuganathan
    Susan Branford
    Current Hematologic Malignancy Reports, 2019, 14 : 501 - 506
  • [43] PARP Inhibition Sensitize BCR-ABL1 Positive Cel
    Hiroki, Haruka
    Takagi, Masatoshi
    Ishi, Yuko
    Piao, Jinhua
    Morio, Tomohiro
    BLOOD, 2019, 134
  • [44] The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
    Shanmuganathan, Naranie
    Branford, Susan
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 501 - 506
  • [45] Development of asciminib, a novel allosteric inhibitor of BCR-ABL1
    Rea, Delphine
    Hughes, Timothy P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 171
  • [46] Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib
    Qiang, W.
    Antelope, O.
    Zabriskie, M. S.
    Pomicter, A. D.
    Vellore, N. A.
    Szankasi, P.
    Rea, D.
    Cayuela, J. M.
    Kelley, T. W.
    Deininger, M. W.
    O'Hare, T.
    LEUKEMIA, 2017, 31 (12) : 2844 - 2847
  • [47] PARP Inhibition Sensitize BCR-ABL1 Positive Cell
    Hiroki, Haruka
    Ishii, Yuko
    Piao, Jinhua
    Morio, Tomohiro
    Takagi, Masatoshi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S12 - S12
  • [48] IMATINIB INDUCES MARKED UPREGULATION OF RECOMBINATION ACTIVATING GENE (RAG) EXPRESSION IN BCR-ABL1 POSITIVE LYMPHOID CELLS
    Shahrin, Nur Hezrin
    Thomson, Daniel
    Wadham, Carol
    Schreiber, Andreas
    Branford, Susan
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S85 - S85
  • [49] A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
    Montecchini, Oksana
    Braidotti, Stefania
    Franca, Raffaella
    Zudeh, Giulia
    Boni, Christian
    Sorio, Claudio
    Toffoletti, Eleonora
    Rabusin, Marco
    Tommasini, Alberto
    Decorti, Giuliana
    Stocco, Gabriele
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] BCR-ABL1 level at 3 months predicts outcome
    Nature Reviews Clinical Oncology, 2012, 9 (1) : 4 - 4
12345